3.53% -0.0135

Glucotrack Inc (GCTK)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Glucotrack Inc Stock (GCTK) Company Profile

Glucotrack Inc

Healthcare (1104)

972 (8) 675-7878

301 RT 17 NORTH, RUTHERFORD

Nächster Verdiensttermin

Neueste SEC-Einreichungen

GCTK's Discussions on Twitter

Compare GCTK vs ISRG, BDX, ALC, MDLN, RMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
GCTK Glucotrack Inc	0.3685	2.31M	0	-16.89M	-16.44M	-20.88
ISRG Intuitive Surgical Inc	406.78	144.07B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	143.98	39.67B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	64.68	31.54B	10.63B	819.00M	1.59B	1.6577
MDLN Medline Inc	35.94	30.39B	29.14B	1.07B	1.05B	1.1956
RMD Resmed Inc	188.63	27.36B	5.54B	1.52B	1.74B	10.37

Glucotrack Inc Aktie (GCTK) Neueste Nachrichten

Finanzdaten der Glucotrack Inc-Aktie (GCTK)

Glucotrack Inc (GCTK)

Glucotrack Inc Stock (GCTK) Company Profile

Compare GCTK vs ISRG, BDX, ALC, MDLN, RMD

Glucotrack Inc Aktie (GCTK) Neueste Nachrichten

GCTK Stock Is Soaring Today — What Is Fueling The Surge? - Stocktwits

GlucoTrack Inc (GCTK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

GlucoTrack Inc (GCTK) Institutional Confidence - TradingKey

GlucoTrack Inc (GCTK) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

GlucoTrack Inc (GCTK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

GlucoTrack Inc (GCTK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

GlucoTrack Inc (GCTK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

GlucoTrack Inc (GCTK) Valuation: PE, PB & Fair Value Analysis - TradingKey

GlucoTrack Inc (GCTK) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

GlucoTrack Inc (GCTK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Glucotrack (NASDAQ: GCTK) seeks reverse split, warrant repricing and auditor ratification - Stock Titan

EBIT per share of GlucoTrack, Inc. – NASDAQ:GCTK - TradingView

GLUCOTRACK INC (GCTK) Stock Chart - ChartMill

GCTK Stock Price, Quote & Chart | GLUCOTRACK INC (NASDAQ:GCTK) - ChartMill

Glucotrack CEO explains tech behind long-term CBGM implant - Drug Delivery Business

Glucotrack Inc Highlights Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association 2026 Scientific Sessions - marketscreener.com

Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association’s 2026 Scientific Sessions - The Manila Times

Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association's 2026 Scientific Sessions - Moomoo

Implantable glucose sensor designed for multi-year use without wearables - Stock Titan

GlucoTrack Inc. (GCTK) Surges 8%: Testing Key Resistance at $0.53PCR Spike - The Legal Advocate

GlucoTrack Inc. (GCTK) Rallies 8.23% as Shares Test Key Resistance LevelBlock Trade Flow - thelegaladvocate.com

GlucoTrack Inc. (GCTK) Rebounds Sharply: Bullish Momentum Building Above SupportContinuation Pattern Picks - The Legal Advocate

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session - Sahm

GlucoTrack Faces Multiple Nasdaq Deficiency Notices, Delisting Risk - TipRanks

Glucotrack receives Nasdaq delisting notice over listing rule deficiencies By Investing.com - Investing.com South Africa

Glucotrack receives Nasdaq delisting notice over listing rule deficiencies - Investing.com

Glucotrack Received Notice of Delisting - TradingView

Glucotrack (GCTK) cited for bid price and equity Nasdaq deficiencies - Stock Titan

Armistice Capital (GCTK) reports 102,115 shares, 4.99% ownership - Stock Titan

Glucotrack Reports Q1 2026 Results and Advances IDE Submission for Implantable Glucose Monitor - Minichart

Glucotrack's 3-Year CGM Aims to Revolutionize Diabetes Management - BriefGlance

TradingKey - TradingKey

Glucotrack 1Q Loss/Shr $2.65 >GCTK - Moomoo

Glucotrack Reports Q1 2026 Net Loss of $4.3M, Cash $3.9M, Files IDE for Implantable CBGM - TradingView

Glucotrack, Inc. Q1 2026: Net loss $(4.33M), EPS $(2.65) — 10-Q Summary - TradingView

Glucotrack, Inc. Submits IDE Application to FDA for Implantable Continuous Blood Glucose Monitoring System and Reports Q1 2026 Financial Results - Quiver Quantitative

Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights - The Manila Times

GlucoTrack, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

Glucotrack (GCTK) posts Q1 loss as cash tightens and Nasdaq flags delisting - Stock Titan

Glucotrack (NASDAQ: GCTK) Q1 2026 results, IDE filing and cash runway - Stock Titan

Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights - GlobeNewswire Inc.

GlucoTrack Stock Short Interest Rises to 59.4% - Moomoo

GlucoTrack, Sarepta, TNF Pharma Dominate Weekly Retail Health Care Buzz — Here’s Why - MSN

What you need to know before buying GlucoTrack (GCTK) (+0.76%) 2026-05-08Mid Cap Momentum - newser.com

How GlucoTrack (GCTK) maintains its asset base | GCTK: GlucoTrack Q Results Lack Revenue, EPS DataFinancial Summary - newser.com

GlucoTrack Files IDE for Implantable Glucose Monitor - TipRanks

IDE filing advances Glucotrack (NASDAQ: GCTK) implantable glucose monitor - Stock Titan

Glucotrack Submits Blood Glucose Monitoring Technology to FDA - Yahoo Finance

Glucotrack Submits IDE Application for U.S. Clinical Study of Its Implantable Continuous Blood Glucose Monitoring System - citybiz

Finanzdaten der Glucotrack Inc-Aktie (GCTK)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie GCTK